SuperScript IV First-Strand Synthesis System, Each and 3 more items

The University of Virginia awarded contract A207_PO-0456490 to Life Technologies Corporation on July 9, 2026, for the procurement of molecular biology reagents and assay materials. The contract, valued at $692.00, encompasses four distinct line items to be delivered to Angela K. Best-Campbell. The primary product is one SuperScript IV First-Strand Synthesis System, priced at $326.63, which is utilized in complementary DNA (cDNA) synthesis for molecular biology applications.

The remaining contract value consists of three TaqMan Gene Expression Assay kits, which are quantitative polymerase chain reaction (qPCR) reagent systems designed for gene expression analysis. These include two 75-reaction assay kits (Assay IDs Mm00516104_m1 and Mm00491032_m1, each priced at $103.24) and one 250-reaction assay kit (Assay ID Mm00461840_m1, priced at $159.04). The materials are designated as inventoried stock and support molecular research activities at the University of Virginia. No annual value, separate contract amount, or specific period of performance beyond the award date is indicated in the contract documentation.